Qube Research & Technologies (QRT)’s Morgan Stanley MS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$23.8M Sell
144,600
-152,300
-51% -$26.4M 0.03% 785
2025
Q4
$52.7M Buy
296,900
+32,200
+12% +$5.37M 0.05% 467
2025
Q3
$42.1M Sell
264,700
-244,900
-48% -$36.2M 0.04% 540
2025
Q2
$71.8M Buy
509,600
+138,900
+37% +$17.1M 0.07% 352
2025
Q1
$43.2M Buy
370,700
+295,500
+393% +$38.1M 0.05% 459
2024
Q4
$9.45M Buy
75,200
+11,600
+18% +$1.43M 0.01% 1127
2024
Q3
$6.63M Sell
63,600
-300,300
-83% -$30.2M 0.01% 1256
2024
Q2
$35.4M Sell
363,900
-90,800
-20% -$8.64M 0.06% 405
2024
Q1
$42.8M Sell
454,700
-23,300
-5% -$2.05M 0.07% 341
2023
Q4
$44.6M Buy
478,000
+211,200
+79% +$16.9M 0.09% 290
2023
Q3
$21.8M Buy
+266,800
New +$23.2M 0.06% 396

Other funds holding MS

Qube Research & Technologies (QRT)'s MS Position: Q1 2026 in Review

Qube Research & Technologies (QRT) reduced its Morgan Stanley (MS) stake by 45% in Q1 2026, selling an estimated $153M and leaving 1,074,334 shares worth $177M. The position accounts for 0.2% of the portfolio, ranked #111.

Qube Research & Technologies (QRT) first reported a position in MS in Q1 2018 and has held it in 27 quarters since. The position peaked at $347M in Q4 2025. 2,489 funds tracked by Wall St. Rank hold MS as of Q1 2026.

  • Qube Research & Technologies (QRT) held 1,074,334 shares of Morgan Stanley worth $177M as of Q1 2026.
  • Qube Research & Technologies (QRT) sold 881,658 Morgan Stanley shares in Q1 2026, an estimated $153M.
  • Morgan Stanley made up 0.2% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #111 holding.
  • Qube Research & Technologies (QRT) first reported a position in Morgan Stanley in Q1 2018 and has held it in 27 quarters since.
  • Qube Research & Technologies (QRT)'s Morgan Stanley position peaked at $347M in Q4 2025.
  • 2,489 funds tracked by Wall St. Rank held Morgan Stanley as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.